FDA Berates Pfizer CEO's Suggestion To Take More Paxlovid If COVID-19 Symptoms Rebound

  • The FDA berates Pfizer Inc PFE CEO Albert Bourla's proposed solution in cases where virus levels rebound after the first course of treatment.
  • After reports said some patients who took Paxlovid rebounded and started feeling symptoms again, the CEO told Bloomberg that patients can take another course, "like you do with antibiotics."
  • "Paxlovid does what it has to do: It reduces the viral load," Bourla, Ph.D., told Bloomberg in an interview. "Then your body is supposed to do the job."
  • The FDA is not in support of the suggestion.
  • "There is no evidence of benefit at this time for a longer course of treatment … or repeating a treatment course of Paxlovid in patients with recurrent COVID-19 symptoms following completion of a treatment course," John Farley, M.D., director of the Office of Infectious Diseases, said in a post.
  • The pill is prescribed as a five-day course, and the FDA document reads that it is "not authorized for use for longer than 5 consecutive days."
  • In Q1 FY22, Paxlovid generated $1.5 billion in sales, and Pfizer forecasts $22 billion in global sales from Paxlovid in FY22.
  • Price Action: PFE shares are down 2.73% at $48.32 during the market session on the last check Thursday.

Posted In: BriefsCOVID-19 CoronavirusBiotechLarge CapNewsHealth CareFDAGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.